参考文献
［1］Lancaster M A，Renner M，Martin C A，et al.Cerebral organoids model human brain development and microcephaly.Nature，2013，501：373-379.
［2］Tuveson D，Clevers H.Cancer modeling meets human organoid technology.Science，2019，364：952-955.
［3］Sachs N，de Ligt J，Kopper O，et al.A living biobank of breast cancer organoids captures disease heterogeneity.Cell，2018，172：373-386.
［4］Vlachogiannis G，Hedayat S，Vatsiou A，et al.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.Science，2018，359：920-926.
［5］Boretto M，Maenhoudt N，Luo X，et al.Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening.Nat Cell Biol，2019，21：1041-1051.
［6］Lynch H T，Snyder C L，Shaw T G，et al.Milestones of Lynch syndrome：1895-2015.Nat Rev Cancer，2015，15：181-194.
［7］Yao X，Smolka A J.Gastric parietal cell physiology and Helicobacter pylori-Induced disease.Gastroenterology，2019，156：2158-2173.
［8］Skardal A，Shupe T，Atala A.Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.Drug Discov Today，2016，21：1399-1411.
［9］Mo X，Niu Q，Ivanov A A，et al.Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.Cell，2022，185：1974-1985.
［10］Yao X.Modeling cellular polarity，plasticity，and disease disparity in 4D.J Mol Cell Biol，2020，12：559-561.
［11］Hiratsuka K，Miyoshi T，Kroll K T，et al.Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery.Sci Adv，2022，8：eabq0866.
［12］Kimura M，Iguchi T，Iwasawa K，et al.En masse organoid phenotyping informs metabolicassociated genetic susceptibility to NASH.Cell，2022，185：4216-4232.
［13］Bhaduri A，Andrews M G，Kriegstein A R，et al.Are organoids ready for prime time？Cell Stem Cell，2020，27：361-365.
［14］Rajasekar S，Lin D S Y，Abdul L，et al.IFlow Plate-a customized 384-well plate for the culture of perfusable vascularized colon organoids.Adv Mater，2020，32：e2002974.
［15］Sakurai M，Ishitsuka K，Ito R，et al.Chemically defined cytokine-free expansion of human haematopoietic stem cells.Nature，2023，615：127-133.(https://www.daowen.com)
［16］Bouffi C，Wikenheiser-Brokamp K A，Chaturvedi P，et al.In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice.Nat Biotechnol，2023.
［17］Koh V，Chakrabarti J，Torvund M，et al.Hedgehog transcriptional effector GLI mediates m TOR Induced PD L1 expression in gastric cancer organoids.Cancer Lett，2021，518：59-71.
［18］Kuen J，Darowski D，Kluge T，et al.Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model.PLoS One，2017，12：e0182039.
［19］Grebenyuk S，Ranga A.Engineering organoid vascularization.Front Bioeng Biotechnol，2019，7：39.
［20］Mansour A A，Goncalves J T，Bloyd C W，et al.An in vivo model of functional and vascularized human brain organoids.Nat Biotechnol，2018，36：432-441.
［21］Shi Y，Sun L，Wang M，et al.Vascularized human cortical organoids（v Organoids）model cortical development in vivo.PLoS Biol，2020，18：e3000705.
［22］Wang Y，Takeishi K，Li Z，et al.Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks.Organogenesis，2017，13：83-94.
［23］Shirure V S，Bi Y，Curtis M B，et al.Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids.Lab Chip，2018，18：3687-3702.
［24］Low J H，Li P，Chew E G Y，et al.Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network.Cell Stem Cell，2019，25：373-387.
［25］Qian X，Nguyen H N，Song M M，et al.Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure.Cell，2016，165：1238-1254.
［26］Rowe R G，Daley G Q.Induced pluripotent stem cells in disease modelling and drug discovery.Nat Rev Genet，2019，20：377-388.
［27］Bhaduri A，Andrews M G，Mancia Leon W，et al.Cell stress in cortical organoids impairs molecular subtype specification.Nature，2020，578：142-148.
［28］Dijkstra K K，Cattaneo C M，Weeber F，et al.Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids.Cell，2018，174：1586-1598.
［29］Bock C，Boutros M，Camp J G，et al.The organoid cell atlas.Nat Biotechnol，2021，39：13-17.
［30］Brancati G，Treutlein B，Camp J G.Resolving neurodevelopmental and vision disorders using organoid single-cell multi-omics.Neuron，2020，107：1000-1013.